help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 26, 2003
Molecular Endocrinology, doi:10.1210/me.2003-0196
A more recent version of this article appeared on February 1, 2004
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
18/2/291    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leong, H.
Right arrow Articles by Bjeldanes, L. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leong, H.
Right arrow Articles by Bjeldanes, L. F.

Submitted on May 27, 2003
Accepted on November 18, 2003

Potent ligand-independent estrogen receptor activation by 3,3'-diindolylmethane is mediated by cross-talk between the PKA and MAPK signaling pathways

Hoyee Leong1, Jacques E. Riby1, Gary L. Firestone1, and Leonard F. Bjeldanes1*

1 Departments of Nutritional Sciences and Toxicology (H.L., J.E.R., L.F.B.) and Molecular and Cell Biology (G.L.F.), University of California, Berkeley, CA 94720

* To whom correspondence should be addressed. E-mail: lfb{at}nature.berkeley.edu.

We investigated the mechanism of ligand-independent activation of the estrogen receptor (ER) by 3,3'-diindolylmethane (DIM), a promising anticancer agent derived from vegetables of the Brassica genus, in Ishikawa and HEC-1B human endometrial cancer cells. DIM stimulated the activity of an ER-responsive reporter by over 40 fold, equivalent to the maximum induction produced by estradiol (E2) while cotreatment of cells with the ER antagonist, ICI-182,780 (ICI), abolished the stimulatory effect of DIM. DIM also induced the expressions of the endogenous genes, transforming growth factor-{alpha} (TGF-{alpha}), alkaline phosphatase (AP), and progesterone receptor (PR) similar to levels induced by E2. Induction of gene expression by DIM was inhibited by the protein synthesis inhibitor, cycloheximide. In addition, cotreatment of cells with the PKA inhibitor, H89, or the MAPK inhibitor, PD98059, reduced DIM activation of the ER by 75% and 50%, respectively. Simultaneous treatment of cells with both inhibitors completely abolished the effect of DIM. DIM stimulated MAPK activity and induced phosphorylation of the endogenous PKA target, cyclic AMP response element binding protein (CREB), in a PKA-dependent manner. Expression of MCREB, a nonphosphorylatable CREB mutant, partially abolished activation of the ER by DIM. These results demonstrate that DIM is a mechanistically novel activator of the ER that requires PKA-dependent phosphorylation of CREB.


Key words: estrogen receptor • CREB • endometrial cancer • ligand-independent activation • DIM

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα
Ligands:   17β-Estradiol



This article has been cited by other articles:


Home page
EndocrinologyHome page
Y.-J. Chen, M.-T. Lee, H.-C. Yao, P.-W. Hsiao, F.-C. Ke, and J.-J. Hwang
Crucial Role of Estrogen Receptor-{alpha} Interaction with Transcription Coregulators in Follicle-Stimulating Hormone and Transforming Growth Factor {beta}1 Up-Regulation of Steroidogenesis in Rat Ovarian Granulosa Cells
Endocrinology, September 1, 2008; 149(9): 4658 - 4668.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. C. Tilton, J. D. Hendricks, G. A. Orner, C. B. Pereira, G. S. Bailey, and D. E. Williams
Gene expression analysis during tumor enhancement by the dietary phytochemical, 3,3'-diindolylmethane, in rainbow trout
Carcinogenesis, July 1, 2007; 28(7): 1589 - 1598.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. C. Tilton, S. A. Givan, C. B. Pereira, G. S. Bailey, and D. E. Williams
Toxicogenomic Profiling of the Hepatic Tumor Promoters Indole-3-Carbinol, 17{beta}-Estradiol and {beta}-Naphthoflavone in Rainbow Trout
Toxicol. Sci., March 1, 2006; 90(1): 61 - 72.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Acconcia, C. J. Barnes, and R. Kumar
Estrogen and Tamoxifen Induce Cytoskeletal Remodeling and Migration in Endometrial Cancer Cells
Endocrinology, March 1, 2006; 147(3): 1203 - 1212.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society